LES Foundation | LESI | Print Page | Contact Us | Sign In | Join
Share |


LES hosts monthly webinars as part of its ongoing Webinar Wednesday series, as well as hot topic webinars that are periodically scheduled to cover breaking developments such as patent reform, important case updates, and other major industry news. Webinar Wednesday is held on the second Wednesday of each month at 1:00 p.m. Eastern Time (EST), and are also available anytime on-demand. Join intellectual property (IP) and licensing experts as they share their knowledge and experience regarding today’s most relevant licensing trends and challenges from transnational issues to ethics to valuation.

If you would like to propose or present a topic, please complete this form.

*FREE for LES members: All webinars, a $1,500 value, are FREE for LES members. Register today!

Who Should Attend

The webinars are designed for all IP and licensing professionals at any level of experience, including corporate IP and licensing professionals, technology transfer professionals, non-IP attorneys, and business development professionals.

Why You Should Attend

LES webinars are a convenient and affordable way to stay up-to-date with current trends and challenges, gain core knowledge on IP and licensing topics, and supplement your learning in new areas. With our live webinars and growing library of on-demand webinars, you can log-in and learn from leading industry experts anywhere, anytime.

Course Details

Each webinar is 60 or 90 minutes and addresses a unique topic presented by different industry experts. Sample topics include patent reform, trademark licensing, royalty auditing, patent sales agreements, antitrust issues, and patent licensing conflicts.

Course Fees

The Webinar Wednesday series is FREE to LES members! These webinars, delivered right to your desk, expand your knowledge and exposure to today’s hot topics.



Meet the New CEO


Date: Wednesday, February 8, 2017

Time: 1:00 pm – 2:30 pm Eastern Time | 1 hour, 30 minutes


During this special Webinar Wednesday webcast Matthew McNeil, Director of Education, LES Board of Directors  will introduce Kim Chotkowski, the new CEO of LES. Kim will share her vision of the future of LES and what that means for your membership. "It is an exciting time for the Company. As we continue to make progress on our 2020 vision and further enhance the LES value proposition we have been and will continue to seek your input. We have developed a set of priorities and aligned our resources to those priorities. Join us as Kim will communicate those priorities and changes that lie ahead.


Note regarding CLE: LES is re-evaluating its policy and procedure as it relates to CLE credits with the intent of increasing what is offered and simplifying the process.  As that effort continues, LES will not be seeking CLE approval for this particular webinar course, but we will return to that practice shortly.

RegisterLife Sciences – Deal Terms:
Do You Really Know What's Happening in Your Therapeutic Areas?

LES USA & Canada & LES International Global Life Sciences
Royalty Rate and Deal Terms Survey 2016

Date: Thursday, February 9, 2017

Time: 12:00 pm – 1:00 pm Eastern Time


Many sources of information on biopharmaceutical royalty rates and deal terms rely on either Freedom of Information (FOI) sources from public companies in the United States, which only represent "material" deals that are generally more than five years old, or rely on press releases or public announcements which are often positioned for maximum publicity or promotional impact (i.e., the hyperbole of "BIO Bucks"). 

The Life Sciences Sectors of LES USA & Canada and LES International have partnered to conduct a landmark GLOBAL survey of royalty rates and deal terms for recent deals conducted in the past two years. The results represent significant information on early stage deals from universities, private biotech companies and deals submitted by international companies outside the USA and Canada. 

This landmark global survey is unique for the biopharmaceutical industry. The results presented in this session will be highlights of the Survey Report to be published in February 2017.  The findings provide insights certain to raise questions or challenge conventional thinking, especially for contemporary deals in recent and turbulent years.

James A. McCarthy, CLP, Corporate and Business Development, Corp Dev Ventures
Jennifer L. Dyer, CLP, Executive Director, University of Southern California, USC Stevens Center for Innovation
Elizabeth Gildea, Licensing Director, GE Healthcare
Sean Sheridan, PhD, Principal, Charles River Associates